Chevron: Prolonged Iran War A Catalyst

Understand this faster with AI
The Asian Investor31.8K FollowersFollow5ShareSavePlay(9min)CommentsSummaryChevron Corporation stands to benefit significantly from Middle East conflict-driven oil price surges, creating a powerful near term earnings and free cash flow catalyst.CVX could see an estimated ~$1.7B earnings boost in Q1'26 due to higher average crude oil prices, supporting accelerated stock buybacks and a potential revaluation.CVX shares currently trade at 18.7X forward P/E, with a justified target of 20.0X if petroleum prices stay above $100 per barrel.Risks include a rapid resolution to the Iran conflict or production slowdowns in Guyana and the Permian Basin, which could normalize prices and pressure earnings. AlexLMX/iStock via Getty Images Chevron Corporation (CVX) is set to be a major beneficiary of the recent escalation in the Middle East as the war between the U.S. and Israel on one side, and Iran on the other, is dragging onThis article was written byThe Asian Investor31.8K FollowersFollowI am interested in a lot of technology and AI stocks like Google, Nvidia, AMD, Tesla and Amazon.Analyst’s Disclosure: I/we have a beneficial long position in the shares of CVX, XOM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
